p34cdc2 in invasive breast cancer:: relationship to DNA content, Ki67 index and c-erbB-2 expression

被引:0
|
作者
Wiesener, B
Hauser-Kronberger, CE
Zipperer, E
Dietze, O
Menzel, C
Hacker, GW
机构
[1] Gen Hosp, St Johanns Spital, Inst Pathol Anat, A-5020 Salzburg, Austria
[2] Gen Hosp, St Johanns Spital, Dept Gynecol & Obstet, A-5020 Salzburg, Austria
关键词
c-erbB-2; DNA ploidy; invasive mammary carcinoma; Ki67; p34(cdc2);
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Aims: One-hundred and eighty-eight cases of human mammary carcinoma were examined immunohistochemically for their expression of Ki67, p34(cdc2) and c-erbB-2. DNA image cytometry was performed to evaluate DNA ploidy, Auer type, S-phase fraction (SPF), 5c exceeding rate (5cER) and 2c deviation index (2cDI). Methods and results: One-hundred and sixty-eight cases were invasive ductal carcinomas, 20 were of invasive lobular type. Routinely assessed oestrogen and progesterone receptor scores were available, The results were analysed statistically in comparison to tumour type, histopathological grade, lymph node status, menopausal status, patient age and overall survival. Ki67 (P<0.002) and c-erbB-2 (P<0.0001) correlated well with overall survival (P<0.0008) and grade (P<0.038) but not: with lymph node status and tumour type. p34cdc2 showed a trend towards a positive correlation with Ki67 (P<0.058) and a significant negative correlation with receptor status (P<0.008) but with none of the other parameters examined. Conclusions: No association between the DNA measured parameters (Auer type, SPF, 5cER and 2cDI) and survival was found. Our results suggest that c-erbB-2 and Ki67 are parameters which might, in combination with receptor status, help to define subgroups with different outcomes.
引用
收藏
页码:522 / 530
页数:9
相关论文
共 50 条
  • [21] The prognostic significance of epidermal growth factor receptor (EGFR), C-erbB-2, Ki-67 and PCNA expression in breast cancer
    Ioachim, E
    Kamina, S
    Athanassiadou, S
    Agnantis, NJ
    ANTICANCER RESEARCH, 1996, 16 (5B) : 3141 - 3147
  • [22] EGFR and c-erbB-2 expression in breast cancer progression
    Chong, D
    Reeves, J
    Cooke, T
    George, WD
    Mallon, E
    Ozanne, B
    Stanton, P
    BRITISH JOURNAL OF CANCER, 1998, 78 : 24 - 24
  • [23] Quantitation of EGFR and c-erbB-2 expression in preinvasive compared to invasive breast cancer.
    Chong, D
    Reeves, J
    Cooke, T
    George, WD
    Mallon, E
    Ozanne, B
    Stanton, F
    BRITISH JOURNAL OF CANCER, 1998, 78 : 68 - 68
  • [24] Maspin and c-erbB-2 expression in correlation with microvessel density in invasive ductal breast cancer
    Sopel, M
    Kasprzyk, I
    Berdowska, I
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2005, 43 (02) : 109 - 116
  • [25] SIMULTANEOUS ANALYSIS OF C-ERBB-2 EXPRESSION AND DNA CONTENT IN BREAST-CANCER USING FLOW-CYTOMETRY
    STAL, O
    SULLIVAN, S
    SUN, XF
    WINGREN, S
    NORDENSKJOLD, B
    CYTOMETRY, 1994, 16 (02): : 160 - 168
  • [26] c-erbB-2/neu protein expression, DNA ploidy and S phase in breast cancer
    Dittadi, R
    Calderazzo, F
    Cabrelle, A
    DiFresco, S
    Gion, M
    ChiecoBianchi, L
    CELL PROLIFERATION, 1996, 29 (07) : 403 - 412
  • [27] Immunohistochemical study of c-erbB-2 expression in primary breast cancer
    Chearskul, S
    Onreabroi, S
    Churintrapun, M
    Semprasert, N
    Bhothisuwan, K
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2001, 19 (03): : 197 - 205
  • [28] PROGNOSTIC IMPORTANCE OF C-ERBB-2 EXPRESSION IN BREAST-CANCER
    GUSTERSON, BA
    GELBER, RD
    GOLDHIRSCH, A
    PRICE, KN
    SAVESODERBORGH, J
    ANBAZHAGAN, R
    STYLES, J
    RUDENSTAM, CM
    GOLOUH, R
    REED, R
    MARTINEZTELLO, F
    TILTMAN, A
    TORHORST, J
    GRIGOLATO, P
    BETTELHEIM, R
    NEVILLE, AM
    BURKI, K
    CASTIGLIONE, M
    COLLINS, J
    LINDTNER, J
    SENN, HJ
    JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (07) : 1049 - 1056
  • [29] Differences in Ki67 and c-erbB2 expression between screen-detected and true interval breast cancers
    Crosier, M
    Scott, D
    Wilson, RG
    Griffiths, CDM
    May, FEB
    Westley, BR
    CLINICAL CANCER RESEARCH, 1999, 5 (10) : 2682 - 2688
  • [30] 胃癌组织中C-erbB-2和ki67的表达及临床意义
    贾振军
    韩金声
    李华新
    中国现代普通外科进展, 2014, 17 (07) : 552 - 554